Xie et al. have also shown that LRIG1 functions as a tumor suppressor in the pathogenesis of glioma via EGFR/Akt/c-Myc activation by using RNA interference (RNAi) that may effectively downregulate LRIG1 gene expression [18]. The gene discussed is EGFR; the disease is central nervous system cancer.